Definition of human rotavirus serotypes by plaque reduction assay.
Twenty different human rotavirus reassortants were characterized serologically by a plaque reduction assay as belonging to one of three distinct serotypes. Fourteen were similar if not identical to our prototype Wa strain; two were like the prototype DS-1 strain, and four belonged to a third serotype for which a prototype has not yet been selected. Hyperimmune sera raised against the three serotypes were required to distinguish among them, since postinfection sera had lower titers and were more cross-reactive than hyperimmune sera. These results confirmed the ability of a qualitative cytopathic neutralization test to predict correctly the Wa or DS-1 serotype. A strain of rhesus rotavirus (MMU 18006) was identified as belonging to the newly defined third serotype. Finally, an attempt was made to correlate previously published serotype analysis by neutralization of fluorescent cell-forming units with the results determined by the plaque reduction neutralization assay.
D003429:Cross Reactions; D003588:Cytopathogenic Effect, Viral; D006801:Humans; D007106:Immune Sera; D009500:Neutralization Tests; D012087:Reoviridae / Q000145:classification*; D012088:Reoviridae Infections / Q000276:immunology; D012401:Rotavirus / Q000145:classification* / Q000254:growth & development / Q000276:immunology; D012703:Serotyping; D010948:Viral Plaque Assay
D007106:Immune Sera